Jesus Ramirez-Bermudez1, Jesus Higuera-Calleja2, Mariana Espinola-Nadurille1, Teresa Corona3. 1. Department of Neuropsychiatry, National Institute of Neurology and Neurosurgery of Mexico, Mexico City, Mexico. 2. Department of Neuroradiology, National Institute of Neurology and Neurosurgery of Mexico, Mexico City, Mexico. 3. Department of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery of Mexico, Mexico City, Mexico.
Abstract
INTRODUCTION: The purpose of this study was to explore the presence of neuropsychiatric disorders in patients with neurocysticercosis (NCC). METHOD: Patients with untreated NCC (n = 45) and healthy controls (n = 45) underwent psychiatric and neuropsychological assessments. RESULTS: The majority of patients in the NCC group (64.4%) had at least 1 psychiatric diagnosis, compared with a minority in the control group (31.1%). The frequency of neurocognitive disorders, and particularly dementia (major neurocognitive disorder), was significantly higher in the group of patients with NCC. DISCUSSION: This study confirms the relationship between NCC and cognitive disorders.
INTRODUCTION: The purpose of this study was to explore the presence of neuropsychiatric disorders in patients with neurocysticercosis (NCC). METHOD:Patients with untreated NCC (n = 45) and healthy controls (n = 45) underwent psychiatric and neuropsychological assessments. RESULTS: The majority of patients in the NCC group (64.4%) had at least 1 psychiatric diagnosis, compared with a minority in the control group (31.1%). The frequency of neurocognitive disorders, and particularly dementia (major neurocognitive disorder), was significantly higher in the group of patients with NCC. DISCUSSION: This study confirms the relationship between NCC and cognitive disorders.
Authors: Alexandra Buda; Owen Dean; Heather R Adams; Sylvia Mwanza-Kabaghe; Michael J Potchen; Esau G Mbewe; Pelekelo P Kabundula; Sarah Mohajeri Moghaddam; Milimo Mweemba; Beauty Matoka; Manoj M Mathews; Gretchen L Birbeck; David R Bearden Journal: Pediatr Neurol Date: 2019-08-06 Impact factor: 3.372